CRNX
Crinetics Pharmaceuticals, Inc. · Healthcare
Chief Scientific Officer Stephen F. Betz sold $160K of Crinetics Pharmaceuticals, Inc.
Sold$160,290
$53.43Price
3,000Shares
−4%Stake
What CRNX did after the filing
- The stock from Fri, Jul 26 close, $54.36
- −3.9%
- S&P 500, same days
- +0.4%
Measured over 30 trading days, to the Sep 9 close.
Traded Thu, Jul 25. Filed Fri, Jul 26, 12:38 PM ET, during the session. Returns use the Jul 26 close and the Sep 9 close. Not investment advice.